Methylphenidate vs Anti-Parkinson’s Agents (Dopamine Agonist)

Interacting Drugs
Methylphenidate
vs
Anti-Parkinson's Agents (Dopamine Agonist)
Security Level
Minor, Monitor Therapy
Mechanism
Anti-Parkinson's Agents (Dopamine Agonist): Methylphenidate may enhance the adverse/toxic effect of Anti-Parkinson's Agents (Dopamine Agonist).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Methylphenidate vs Anti-Parkinson’s Agents (Dopamine Agonist)